Increasing R&D by the Pharma Companies for New Drug Development is Surging the Market Growth
The increasing R&D by the pharma companies for new drug development, high prevalence of colorectal cancer, rising government initiative to create awareness among people along with escalating investment by the market players to develop early detection of test kit are some of the major factors projected to fuel the growth of China Colorectal cancer market . Colorectal cancer (CRC) is a major public health concern as it is among the third most common cancer in China after lung cancer. Moreover, surging government initiative by launching various awareness campaign on colorectal cancer, escalating late-stage pipeline therapies and launch of angiogenesis inhibitors by the market player in China for the treatment of colorectal cancer are proliferating the growth of the market in the coming years. Based on Solution, Diagnosis segment is anticipated to register fastest growth in the China Colorectal Cancer market in 2020 on account of introduction of screening program by ...